The Jak-STAT pathway

Molecular Immunology

Volumn 37, Issue 1-2, 2000, Pages 1-11

  Imada, Kazuroni ^a   Leonard, Warren J ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR; JANUS KINASE; STAT PROTEIN; STAT1 PROTEIN; STAT3 PROTEIN; STAT4 PROTEIN; STAT5 PROTEIN; STAT6 PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; CELL FUNCTION; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; DIMERIZATION; GENE EXPRESSION; GENE TARGETING; IN VIVO STUDY; KNOCKOUT MOUSE; LIGAND BINDING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; DNA-BINDING PROTEINS; HUMANS; INTERLEUKIN-2; JANUS KINASE 1; JANUS KINASE 2; JANUS KINASE 3; KILLER CELLS, NATURAL; MICE; MILK PROTEINS; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; STAT1 TRANSCRIPTION FACTOR; STAT3 TRANSCRIPTION FACTOR; STAT4 TRANSCRIPTION FACTOR; STAT5 TRANSCRIPTION FACTOR; STAT6 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS;

ANIMALIA; JANUS;

EID: 0034023759     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(00)00018-3     Document Type: Review

References (127)

1. Akaishi H., Takeda K., Kaisho T., Shineha R., Satomi S., Takeda J., Akira S. Defective IL-2-mediated IL-2 receptor alpha chain expression in Stat3-deficient T lymphocytes. Int. Immunol. 10:1998;1747-1751.
2. Akimoto T., Numata F., Tamura M., Takata Y., Higashida N., Takashi T., Takeda K., Akira S. Abrogation of bronchial eosinophilic inflammation and airway hyperreactivity in signal transducers and activators of transcription (STAT)6-deficient mice. J. Exp. Med. 187:1998;1537-1542.
3. Alexander W.S., Starr R., Fenner J.E., Scott C.L., Handman E., Sprigg N.S., Corbin J.E., Cornish A.L., Darwiche R., Owczarec C.M., Kay T.W.H., Nicola N.A., Hertzog P.J., Metcalf D., Hilton D.J. SOCS1 is a critical inhibitor of interferon γ signaling and prevents the potentially fatal neonatal actions of this cytokine. Cell. 98:1999;597-608.
4. Aman M.J., Migone T.-S., Sasaki A., Ascherman D.P., Zhu M.-h, Soldaini E., Imada K., Miyajima A., Yoshimura A., Leonard W.J. CIS Associates with the Interleukin-2 Receptor β chain and Inhibits IL-2-Dependent Signaling. J. Biol. Chem. 274:1999;30266-30272.
5. Argetsinger L.S., Campbell G.S., Yang X., Witthuhn B.A., Silvennoinen O., Ihle J.N., Carter-Su C. Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase. Cell. 74:1993;237-244.
6. Azam M., Lee C., Strehlow I., Schindler C. Functionally distinct isoforms of STAT5 are generated by protein processing. Immunity. 6:1997;691-701.
7. Bhattacharya S., Eckner R., Grossman S., Oldread E., Arany Z., D'Andrea A., Livingston D.M. Cooperation of Stat2 and p300/CBP in signalling induced by interferon α Nature. 383:1996;344-347.
8. Bromberg J.F., Wrzeszczynska M.H., Devgan G., Zhao Y., Pestell R.G., Albanese C., Darnell J.E. Jr. Stat3 as an oncogene. Cell. 98:1999;295-303.
9. Caldenhoven E., van Dijk T.B., Solari R., Armstrong J., Raaijmakers J.A.M., Lammers J.W.J., Koenderman L., de Groot R.P. STAT3beta, a splice variant of transcription factor STAT3, is a dominant negative regulator of transcription. J. Biol. Chem. 271:1996;13221-13227.
10. Cao X., Shores E.W., Hu-Li J., Anver M.R., Kelsall B.L., Russell S.M., Drago J., Noguchi M., Grinberg A., Bloom E.T., Paul W.E., Katz S.I., Love P.E., Leonard W.J. Defective lymphoid development in mice lacking expression of the common cytokine receptor γ chain. Immunity. 2:1995;223-238.
11. Cella N., Groner B., Hynes N.E. Characterization of Stat5a and Stat5b homodimers and heterodimers and their association with the glucocorticoid receptor in mammary cells. Mol. Cell Biol. 18:1998;1783-1792.
12. Chai S.K., Nichols G.L., Rothman P. Constitutive activation of JAKs and STATs in BCR-Abl-expressing cell lines and peripheral blood cells derived from leukemic patients. J. Immunol. 159:1997;4720-4728.
13. Chung C.D., Liao J., Liu B., Rao X., Jay P., Berta P., Shuai K. Specific inhibition of Stat3 signal transduction by PIAS3. Science. 278:1997;1803-1805.
14. Copeland N.G., Gilbert D.J., Schindler C., Zhong Z., Wen Z., Darnell J.E. Jr, Mui A.L., Miyajima A., Quelle F.W., Ihle J.N., Jenkins N.A. Distribution of the mammalian Stat gene family in mouse chromosomes. Genomics. 29:1995;225-228.
15. Danial N.N., Pernis A., Rothman P.B. Jak-STAT signaling induced by the v-abl oncogene. Science. 269:1995;1875-1877.
16. Darnell J.E. Jr, Kerr I.M., Stark G.R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science. 264:1994;1415-1421.
17. Darnell J.E. Jr. STATs and gene regulation. Science. 277:1997;1630-1635.
18. David M., Petricoin E. III, Benjamin C., Pine R., Weber M.J., Larner A.C. Requirement for MAP kinase (ERK2) activity in interferon alpha- and interferon beta-stimulated gene expression through STAT proteins. Science. 269:1995;1721-1723.
19. DiSanto J.P., Müller W., Guy-Grand D., Fischer A., Rajewsky K. Lymphoid development in mice with a targeted deletion of the interleukin-2 receptor γ chain. Proc. Natl. Acad. Sci. USA. 92:1995;377-381.
20. Durbin J.E., Hackenmiller R., Simon M.C., Levy D.E. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell. 84:1996;443-450.
21. Endo T.A., Masuhara M., Yokouchi M., Suzuki R., Sakamoto H., Mitsui K., Matsumoto A., Tanimura S., Ohtsubo M., Misawa H., Miyazaki T., Leonor N., Taniguchi T., Fujita T., Kanakura Y., Komiya S., Yoshimura A. A new protein containing an SH2 domain that inhibits JAK kinases. Nature. 387:1997;921-924.
22. Feldman G.M., Rosenthal L.A., Liu X., Hayes M.P., Wynshaw-Boris A., Leonard W.J., Hennighausen L., Finbloom D.S. STAT5A-deficient mice demonstrate a defect in granulocyte-macrophage colony-stimulating factor-induced proliferation and gene expression. Blood. 90:1997;1768-1776.
23. Frank S.J., Gilliland G., Kraft A.S., Arnold C.S. Interaction of the growth hormone receptor cytoplasmic domain with the JAK2 tyrosine kinase. Endocrinology. 135:1994;2228-2239.
24. Fujitani Y., Hibi M., Fukada T., Takahashitezuka M., Yoshida H., Yamaguchi T., Sugiyama K., Yamanaka Y., Nakajima K., Hirano T. An alternative pathway for STAT activation that is mediated by the direct interaction between JAK and STAT. Oncogene. 14:1997;751-761.
25. Gingras S., Simard J., Groner B., Pfitzner E. p300/CBP is required for transcriptional induction by interleukin-4 and interacts with Stat6. Nucleic Acids Res. 27:1999;2722-2729.
26. Goh K.C., Haque S.J., Williams B.R. p38 MAP kinase is required for STAT1 serine phosphorylation and transcriptional activation induced by interferons. EMBO J. 18:1999;5601-5608.
27. Gouilleux-Gruart V., Gouilleux F., Desaint C., Claisse J.F., Capiod J.C., Delobel J., Weber-Nordt R., Dusanter-Fourt I., Dreyfus F., Groner B., Prin L. STAT-related transcription factors are constitutively activated in peripheral blood cells from acute leukemia patients. Blood. 87:1996;1692-1697.
28. Hilton D.J., Richardson R.T., Alexander W.S., Viney E.M., Willson T.A., Sprigg N.S., Starr R., Nicholson S.E., Metcalf D., Nicola N.A. Twenty proteins containing a C-terminal SOCS box form five structural classes. Proc. Natl. Acad. Sci. USA. 95:1998;114-119.
29. Horvath C.M., Wen Z., Darnell J.E. Jr. A STAT protein domain that determines DNA sequence recognition suggests a novel DNA-binding domain. Genes Dev. 9:1995;984-994.
30. Horvath C.M., Darnell J.E. The state of the STATs: recent developments in the study of signal transduction to the nucleus. Curr. Opin. Cell Biol. 9:1997;233-239.
31. Hou X.S., Melnick M.B., Perrimon N. Marelle acts downstream of the Drosophila HOP/Jak kinase and encodes a protein similar to the mammalian STATs. Cell. 84:1996;411-419.
32. Ihle J.N. Cytokine receptor signaling. Nature. 377:1995;591-594.
33. Ihle J.N. STATs: signal transducers and activators of transcription. Cell. 84:1996;331-334.
34. Imada K., Bloom E.T., Nakajima H., Horvath-Arcidiacono J.A., Udy G.B., Davey H.W., Leonard W.J. Stat5b is essential for natural killer cell-mediated proliferation and cytolytic activity. J. Exp. Med. 188:1998;2067-2074.
35. John S., Robbins C.M., Leonard W.J. An IL-2 response element in the human IL-2 receptor α chain promoter is a composite element that binds Stat5, Elf-1, HMG-I(Y) and a GATA family protein. EMBO J. 15:1996;5627-5635.
36. John S., Vinkemeier U., Soldaini E., Darnell J.E. Jr, Leonard W.J. The significance of tetramerization in promoter recruitment by Stat5. Mol. Cell. Biol. 19:1999;1910-1918.
37. Kagami, S.-i, Nakajima, H., Kumano, K., Suzuki, K., Suto, A., Imada, K., Davey, H.W., Saito, Y., Takatsu, K., Leonard, W.J., Iwamoto, I., 2000. Both Stat5a and Stat5b are required for antigen-induced eosinophil and T cell recruitment into the tissue. Blood, 95, 1370-1377.
38. Kaplan M.H., Sun Y.L., Hoey T., Grusby M.J. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature. 382:1996;174-177.
39. Kaplan M.H., Schindler U., Smiley S.T., Grusby M.J. Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity. 4:1996;313-319.
40. Kawata T., Shevchenko A., Fukuzawa M., Jermyn K.A., Totty N.F., Zhukovskaya N.V., Sterling A.E., Mann M., Williams J.G. SH2 signaling in a lower eukaryote: a Stat protein that regulates stalk cell differentiation in Dictyostelium. Cell. 89:1997;909-916.
41. Kim T.K., Maniatis T. Regulation of interferon-gamma-activated STAT1 by the ubiquitin-proteasome pathway. Science. 273:1996;1717-1719.
42. Klingmuller U., Lorenz U., Cantley L.C., Neel B.G., Lodish H.F. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell. 80:1995;729-738.
43. Kondo M., Takeshita T., Higuchi M., Nakamura M., Sudo T., Nishikawa S., Sugamura K. Functional participation of the IL-2 receptor gamma chain in IL-7 receptor complexes. Science. 263:1994;1453-1454.
44. Kovanen, P.E., Leonard, W.J., 1999. Inhibitors keep cytokines in check. Current Biology, 9, R899-R902.
45. Kuperman D., Schofield B., Wills-Karp M., Grusby M.J. Signal transducer and activator of transcription factor 6 (Stat6)-deficient mice are protected from antigen-induced airway hyperresponsiveness and mucus production. J. Exp. Med. 187:1998;939-948.
46. Lecine P., Algarte M., Rameil P., Beadling C., Bucher P., Nabholz M., Imbert J. Elf-1 and Stat5 bind to a critical element in a new enhancer of the human interleukin-2 receptor α gene. Mol. Cell. Biol. 16:1996;6829-6840.
47. Leonard W.J. The Molecular Basis of X-linked Combined Immunodeficiency: Defective Cytokine Receptor Signaling. Annu. Rev. Med. 47:1996;229-239.
48. Leonard W.J. Stats and cytokine specificity. Nature Med. 2:1996;968-969.
49. Leonard W.J., O'Shea J.J. Jaks and STATs: Biological implications. Annu. Rev. Immunol. 16:1998;293-322.
50. Leonard W.J. Type I cytokines and interferons and their receptors. Paul W.E. Fundamental Immunology. 4th ed. 1999;741-774 Lippincott Raven Publishers, Philadelphia PA.
51. Lew D.J., Decker T., Strehlow I., Darnell J.E. Overlapping elements in the guanylate-binding protein gene promoter mediate transcriptional induction by alpha and gamma interferons. Mol. Cell. Biol. 11:1991;182-191.
52. Lin J.-X., Mietz J., Modi W.S., John S., Leonard W.J. Cloning of human Stat5B. Reconstitution of interleukin-2-induced Stat5A and Stat5B DNA binding activity in COS-7 cells. J. Biol. Chem. 271:1996;10738-10744.
53. Liu B., Liao J., Rao X., Kushner S.A., Chung C.D., Chang D.D., Shuai K. Inhibition of Stat1-mediated gene activation by PIAS1. Proc. Natl. Acad. Sci. USA. 95:1998;10626-10631.
54. Liu X., Robinson G.W., Wagner K., Garret L., Ulynshaw-Boris A., Hennighausen L. Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev. 11:1997;179-186.
55. Look D.C., Pelletier M.R., Tidwell R.M., Roswit W.T., Holtzman M.J. Stat1 depends on transcriptional synergy with Sp1. J. Biol. Chem. 270:1995;30264-30267.
56. Lowin B., Beermann F., Schmidt A., Tschopp J. A null mutation in the perforin gene impairs cytolytic T lymphocyte- and natural killer cell-mediated cytotoxicity. Proc. Natl. Acad. Sci. USA. 91:1994;11571-11575.
57. Macchi P., Villa A., Gillani S., Sacco M.G., Frattini A., Porta F., Ugazio A.G., Johnston J.A., Candotti F., O'Shea J.J., Vezzoni P., Notarangelo L.D. Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature. 377:1995;65-68.
58. Marine J.-C., Topham D.J., McKay C., Wang D., Parganas E., Stravopodis D., Yoshimura A., Ihle J.N. SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality. Cell. 98:1999;609-616.
59. Marine J.-C., McKay C., Wang D., Topham D.J., Parganas E., Nakajima H., Pendeville H., Yasukawa H., Sasaki A., Yoshimura A., Ihle J.N. SOCS3 is essential in the regulation of fetal liver erythropoiesis. Cell. 98:1999;617-627.
60. Masuhara M., Sakamoto H., Matsumoto A., Suzuki R., Yasukawa H., Mitsui K., Wakioka T., Tanimura S., Sasaki A., Misawa H., Yokouchi M., Ohtsubo M., Yoshimura A. Cloning and characterization of novel CIS family genes. Biochem. Biophys. Res. Commun. 239:1997;439-446.
61. Matsumoto A., Masuhara M., Mitsui K., Yokouchi M., Ohtsubo M., Misawa H., Miyajima A., Yoshimura A. CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation. Blood. 89:1997;3148-3154.
62. Matsumoto A., Seki Y., Kubo M., Ohtsuka S., Suzuki A., Hayashi I., Tsuji K., Nakahata T., Okabe M., Yamada S., Yoshimura A. Suppression of STAT5 functions in liver, mammary glands, and T cells in cytokine-inducible SH2-containing protein 1 transgenic mice. Mol. Cell. Biol. 19:1999;6396-6407.
63. Matsumura I., Kitamura T., Wakao H., Tanaka H., Hashimoto K., Albanese C., Downward J., Pestell R.G., Kanakura Y. Transcriptional regulation of the cyclin D1 promoter by STAT5: its involvement in cytokine-dependent growth of hematopoietic cells. EMBO J. 18:1999;1367-1377.
64. McDonald C., Reich N.C. Cooperation of the transcriptional coactivators CBP and p300 with Stat6. J. Interferon Cytokine Res. 19:1999;711-722.
65. Meraz M.A., White J.M., Sheehan K.C., Bach E.A., Rodig S.J., Dighe A.S., Kaplan D.H., Riley J.K., Greenlund A.C., Campbell D., Carver-Moore K., DuBois R.N., Clark R., Aguet M., Schreiber R.D. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell. 84:1996;431-442.
66. Migone T.S., Lin J.X., Cereseto A., Mulloy J.C., O'Shea J.J., Franchini G., Leonard W.J. Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I. Science. 269:1995;79-81.
67. Mikita T., Daniel C., Wu P., Schindler U. Mutational analysis of the STAT6 SH2 domain. J. Biol. Chem. 273:1998;17634-17642.
68. Moriggl R., Topham D.J., Teglund S., Sexl V., McKay C., Wang D., Hoffmeyer A., van Deursen J., Sangster M.Y., Bunting K.D., Grosveld G.C., Ihle J.N. Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells. Immunity. 10:1999;249-259.
69. Mui A.L., Wakao H., O'Farrell A.M., Harada N., Miyajima A. Interleukin-3, granulocyte-macrophage colony stimulating factor and interleukin-5 transduce signals through two Stat5 homologs. EMBO J. 14:1995;1166-1175.
70. Müller M., Briscoe J., Laxton C., Guschin D., Ziemiecki A., Silvenoinen O., Harpur A.G., Barbier G., Witthuhn B.A., Schindler C., Pellegrini S., Wilks A.F., Ihle J.N., Stark G.R., Kerr I.M. The protein tyrosine kinase JAK1 complements a mutant cell line defective in the interferon-α/β and γ signal transduction pathways. Nature. 366:1993;129-135.
71. Naka T., Narazaki M., Hirata M., Matsumoto T., Minamoto S., Aono A., Nishimoto N., Kajita T., Taga T., Yoshizaki K., Akira S., Kishimoto T. Structure and function of a new STAT-induced STAT inhibitor. Nature. 387:1997;924-929.
72. Naka T., Matsumoto T., Narazaki M., Fujimoto M., Morita Y., Ohsawa Y., Saito H., Nagasawa T., Uchiyama Y., Kishimoto T. Accelerated apoptosis of lymphocytes by augmented induction of Bax in SSI-1 (STAT-induced STAT inhibitor-1) deficient mice. Proc. Natl. Acad. Sci. USA. 95:1998;15577-15582.
73. Nakajima H., Liu X.W., Wynshaw-Boris A., Rosenthal L.A., Imada K., Finbloom D.S., Hennighausen L., Leonard W.J. An indirect effect of Stat5a in IL-2-induced proliferation: a critical role for Stat5a in IL-2-mediated IL-2 receptor α chain induction. Immunity. 7:1997;691-701.
74. Neubauer H., Cumano A., Müller M., Wu H., Huffstadt U., Pfeffer K. Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis. Cell. 93:1998;397-409.
75. Ng J., Cantrell D. STAT3 is a serine kinase target in T lymphocytes. J. Biol. Chem. 272:1997;24542-24549.
76. Noguchi M., Yi H., Rosenblatt H.M., Filipovich A.H., Adelstein S., Modi W.S., McBride O.W., Leonard W.J. Interleukin-2 receptor γ chain mutation results in X-linked severe combined immunodeficiency in humans. Cell. 73:1993;147-157.
77. Noguchi M., Nakamura Y., Russell S.M., Ziegler S.F., Tsang M., Cao X., Leonard W.J. Interleukin-2 receptor γ chain: a functional component of the interleukin-7 receptor. Science. 262:1993;1877-1880.
78. Nosaka T., van Deursen J.M., Tripp R.A., Thierfelder W.E., Witthuhn B.A., McMickle A.P., Doherty P.C., Grosveld G.C., Ihle J.N. Defective lymphoid development in mice lacking Jak3. Science. 270:1995;800-802.
79. Oakes S.A., Candotti F., Johnston J.A., Chen Y.Q., Ryan J.J., Taylor N., Liu X., Hennighausen L., Notarangelo L.D., Paul W.E., Blaese R.M., O'Shea J.J. Signaling via IL-2 and IL-4 in JAK3-deficient severe combined immunodeficiency lymphocytes: JAK3-dependent and independent pathways. Immunity. 5:1996;605-615.
80. O'Shea J.J. Jaks, STATs, cytokine signaling and immunoregulation: Are we there yet? Immunity. 7:1997;1-11.
81. Parganas E., Wang D., Stravopodis D., Topham D.J., Marine J.-C., Teglund S., Vanin E., Bodner S., Colamonici O.R., van Deursen J.M., Grosveld G., Ihle J.N. Jak2 is essential for signaling through a variety of cytokine receptors. Cell. 93:1998;385-395.
82. Park S.Y., Saijo K., Takahashi T., Osawa M., Arase H., Hirayama N., Miyake K., Nakauchi H., Shirasawa T., Saito T. Developmental defects of lymphoid cells in Jak3 kinase-deficient mice. Immunity. 3:1995;771-782.
83. Pfitzner E., Jahne R., Wissler M., Stoecklin E., Groner B. P300/CREB-binding protein enhances the prolactin-mediated transcriptional induction through direct interaction with the transaction domain of Stat5, but does not participate in the Stat5-mediated suppression of the glucocorticoid response. Mol. Endocrinol. 12:1998;1582-1593.
84. Pircher T.J., Petersen H., Gustafsson J.A., Haldosen L.A. Extracellular signal-regulated kinase (ERK) interacts with signal transducer and activator of transcription (STAT) 5a. Mol. Endocrinol. 13:1999;555-565.
85. + severe combined immunodeficiency. Nat. Genet. 20:1998;394-397.
86. Rodig S., Meraz M.A., White J.M., Lampe P.A., Riley J.K., Arthur C.D., King K.L., Sheehan K.C.F., Yin L., Pennica D., Johnson E.M. Jr, Schreiber R.D. Disruption of the Jak1 gene demonstrates obligatory and nonreduntant roles of the Jaks in cytokine-induced biologic responses. Cell. 93:1998;373-383.
87. c chains with Jak1 and Jak3: Implications for XSCID and XCID. Science. 266:1994;1042-1045.
88. Russell S.M., Tayebi N., Nakajima H., Riedy M.C., Roberts J.L., Aman M.J., Migone T.-S., Noguchi M., Markert M.L., Buckley R.H., O'Shea J.J., Leonard W.J. Mutation of Jak3 in a patient with SCID: Essential role of Jak3 in lymphoid development. Science. 270:1995;797-800.
89. Shaefer T.S., Sanders L.K., Nathans D. Cooperative transcriptional activity of Jun and Stat3β, a short form of Stat3. Proc. Natl. Acad. Sci. USA. 92:1995;9097-9101.
90. Shimoda K., van Deursen J., Sangster M.Y., Sarawar S.R., Carson R.T., Tripp R.A., Chu C., Quelle F.W., Nosaka T., Vignali D.A., Doherty P.C., Grosveld G., Paul W.E., Ihle J.N. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature. 380:1996;630-633.
91. Soldaini, E., John, S., Moro, S., Bollenbacher, J., Schindler, U., Leonard, W.J., 2000. DNA binding site selection of dimeric and tetrameric Stat5 proteins reveals a large repertoire of divergent tetrameric Stat5a binding sites. Mol. Cell. Biol., 20, 389-401.
92. Sperisen P., Wang S.M., Soldaini E., Pla M., Rusterholz C., Bucher P., Corthesy P., Reichenbach P., Nabholz M. Mouse interleukin-2 receptor α gene expression: Interleukin-1 and interleukin-2 control transcription via distinct cis-acting elements. J. Biol. Chem. 270:1995;10743-10753.
93. Starr R., Willson T.A., Viney E.M., Murray L.J., Rayner J.R., Jenkins B.J., Gonda T.J., Alexander W.S., Metcalf D., Nicola N.A., Hilton D.J. A family of cytokine-inducible inhibitors of signalling. Nature. 387:1997;917-921.
94. Starr R., Metcalf D., Elefanty A.G., Brysha M., Willson T.A., Nicola N.A., Hilton D.J., Alexander W.S. Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1. Proc. Natl. Acad. Sci. USA. 95:1998;14395-14399.
95. Stocklin E., Wissler M., Gouilleux F., Groner B. Functional interactions between Stat5 and the glucocorticoid receptor. Nature. 383:1996;726-728.
96. Suzuki R., Sakamoto H., Yasukawa H., Masuhara M., Wakioka T., Sasaki A., Yuge K., Komiya S., Inoue A., Yoshimura A. CIS3 and JAB have different regulatory roles in interleukin-6 mediated differentiation and STAT3 activation in M1 leukemia cells. Oncogene. 17:1998;2271-2278.
97. Takeda K., Tanaka T., Shi W., Matsumoto M., Minami M., Kashiwamura S., Nakanishi K., Yoshida N., Kishimoto T., Akira S. Essential role of Stat6 in IL-4 signalling. Nature. 380:1996;627-630.
98. Takeda K., Noguchi K., Shi W., Tanaka T., Matsumoto M., Yoshida N., Kishimoto T., Akira S. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc. Natl. Acad. Sci. USA. 94:1997;3801-3804.
99. Takeda K., Kaisho T., Yoshida N., Takeda J., Kishimoto T., Akira S. Stat3 activation is responsible for IL-6-dependent T-cell proliferation through preventing apoptosis: generation and characterization of T cell-specific Stat3-deficient mice. J. Immunol. 161:1998;4652-4660.
100. Takeda K., Clausen B.E., Kaisho T., Tsujimura T., Terada N., Forster I., Akira S. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity. 10:1999;39-49.
101. Takemoto S., Mulloy J.C., Cereseto A., Migone T.S., Patel B.K., Matsuoka M., Yamaguchi K., Takatsuki K., Kamihira S., White J.D., Leonard W.J., Waldmann T., Franchini G. Proliferation of adult T cell leukemia/lymphoma cells is associated with the constitutive activation of JAK/STAT proteins. Proc. Natl. Acad. Sci. USA. 94:1997;13897-13902.
102. Teglund S., McKay C., Schuetz E., van Deursen J.M., Stravopodis D., Wang D., Brown M., Bodner S., Grosveld G., Ihle J.N. Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell. 93:1998;841-850.
103. Thierfelder W.E., van Deursen J.M., Yamamoto K., Tripp R.A., Sarawar S.R., Carson R.T., Sangster M.Y., Vignali D.A., Doherty P.C., Grosveld G.C., Ihle J.N. Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature. 382:1996;171-174.
104. Thomis D.C., Gurniak C.B., Tivol E., Sharpe A.H., Berg L.J. Defects in B lymphocyte maturation and T lymphocyte activation in mice lacking Jak3. Science. 270:1995;794-797.
105. Turkson J., Bowman T., Adnane J., Zhang Y., Djeu J.Y., Sekharam M., Frank D.A., Holzman L.B., Wu J., Sebti S., Jove R. Requirement for Ras/Rac1-mediated p38 and c-Jun N-terminal kinase signaling in stat3 transcriptional activity induced by the src oncoprotein. Mol. Cell. Biol. 11:1999;7519-7528.
106. Udy G.B., Towers R.P., Snell R.G., Wilkins R.J., Park S.-H., Ram P.A., Waxman D.J., Davey H.W. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc. Natl. Acad. Sci. USA. 94:1997;7239-7244.
107. Urban J.F. Jr, Noben-Trauth N., Donaldson D.D., Madden K.B., Morris S.C., Collins M., Finkelman F.D. IL-13, IL-4Ralpha, and Stat6 are required for the expulsion of the gastrointestinal nematode parasite Nippostrongylus brasiliensis. Immunity. 8:1998;255-264.
108. Velazquez L., Fellous M., Stark G.R., Pellegrini S. A protein tyrosine kinase in the interferon α/β signaling pathway. Cell. 70:1992;313-322.
109. Velazquez L., Mogensen K.E., Barbieri G., Fellous M., Uze G., Pellegrini S. Distinct domains of the protein tyrosine kinase tyk2 required for binding of interferon-alpha/beta and for signal transduction. J. Biol. Chem. 270:1995;3327-3334.
110. Vinkemeier U., Cohen S.L., Moarefi I., Chait B.T., Kuriyan J., Darnell J.E. Jr. DNA binding of in vitro activated Stat1a, Stat1b and truncated Stat1: interaction between NH2- terminal domains stabilizes binding of two dimers to tandem DNA sites. EMBO J. 15:1996;5616-5626.
111. Vinkemeier U., Moarefi I., Darnell J.E. Jr, Kuriyan J. Structure of the amino-terminal protein interaction domain of STAT-4. Science. 279:1998;1048-1052.
112. Wakao H., Gouilleux F., Groner B. Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response. EMBO J. 13:1994;2182-2191.
113. Wang D., Stravopodis D., Teglund S., Kitazawa J., Ihle J.N. Naturally occuring dominant negative variants of Stat5. Mol. Cell. Biol. 16:1996;6141-6148.
114. Watling D., Guschin D., Müller M., Silvennoinen O., Witthuhn B.A., Quelle F.W., Rogers N.C., Schindler C., Startk G.R., Ihle J.N., Kerr I.M. Complementation by the protein tyrosine kinase JAK2 of a mutant cell line defective in the interferon-γ signal transduction pathway. Nature. 366:1993;166-170.
115. Weber-Nordt R.M., Egen C., Wehinger J., Ludwig W., Gouilleux-Gruart V., Mertelsmann R., Finke J. Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines. Blood. 88:1996;809-816.
116. Wen Z., Zhong Z., Darnell J.E. Jr. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell. 82:1995;241-250.
117. Witthuhn B.A., Quellee F.W., Silvennoinen O., Yi T., Tang B., Miura O., Ihle J.N. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell. 74:1993;227-236.
118. Xu X., Sun Y.-L., Hoey T. Cooperative DNA binding and sequence-selective recognition conferred by the STAT amino terminal domain. Science. 273:1996;794-797.
119. Yan R., Small S., Desplan C., Dearolf C.R., Darnell J.E. Jr. Identiication of a STAT gene that functions in Drosophila development. Cell. 84:1996;421-430.
120. Yoshimura A., Ohkubo T., Kiguchi T., Jenkins N.A., Gilbert D.J., Copeland N.G., Hara T., Miyajima A. A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors. EMBO J. 14:1995;2816-2826.
121. Yu C.L., Meyer D.J., Campbell G.S., Larner A.C., Carter-Su C., Schwartz J., Jove R. Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Science. 269:1995;81-83.
122. Yu C.R., Ortaldo J.R., Curiel R.E., Young H.A., Anderson S.K., Gosselin P. Role of a STAT binding site in the regulation of the human perforin promoter. J. Immunol. 162:1999;2785-2790.
123. Zhang J.J., Vinkemeier U., Gu W., Chakravarti D., Horvath C.M., Darnell J.E. Jr. Two contact regions between Stat1 and CBP/p300 in interferon gamma signaling. Proc. Natl. Acad. Sci. USA. 93:1996;15092-15096.
124. Zhang J.J., Zhao Y., Chait B.T., Lathem W.W., Ritzi M., Knippers R., Darnell J.E. Jr. Ser727-dependent recruitment of MCM5 by Stat1alpha in IFN-gamma-induced transcriptional activation. EMBO J. 17:1998;6963-6971.
125. Zhang X., Blenis J., Li H.C., Schidler C., Chen-Kiang S. Requirement of serine phosphorylation for formation of STA-promoter complexes. Science. 267:1995;1990-1994.
126. Zhang Z., Jones S., Hagood J.S., Fuentes N.L., Fuller G.M. STAT3 acts as a co-activator of glucocorticoid receptor signaling. J. Biol. Chem. 272:1997;30607-30610.
127. Zhu M., John S., Berg M., Leonard W.J. Functional association of Nmi with Stat5 and Stat1 in IL-2- and IFNgamma-mediated signaling. Cell. 96:1999;121-130.